Hormone Receptor–Positive Breast Cancer Adjuvant Endocrine Therapy Guidelines Pocket Guide - Guideline Central

Hormone Receptor–Positive Breast Cancer Adjuvant Endocrine Therapy

American Society of Clinical OncologyPublished: December 10, 2018

A PDF version of this Pocket Guide is also available!
$9.95
  • Updated Recommendations on Extended Therapy
  • Recommendations on Ovarian Suppression
  • Table
    • Recommended Pharmaceuticals for HR+ Breast Cancer
    • Prognostic Factors for Recurrence After 5 Years of Adjuvant Endocrine Therapy


You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.